CUSIP: G3141W122
What is CUSIP G3141W122?
CUSIP G3141W122 identifies EUCRW - EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP G3141W122:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q2 | 0 | $0 | -$52,333 | 0 | |
| 2023 Q1 | 1,364,106 | $52,333 | -$6,820 | $0.04 | 19 |
| 2022 Q4 | 1,507,749 | $82,289 | -$1,523 | $0.06 | 20 |
| 2022 Q3 | 1,337,052 | $385,719 | -$1,819 | $0.04 | 14 |
| 2022 Q2 | 1,490,759 | $88,000 | -$10,858 | $0.07 | 13 |
| 2022 Q1 | 1,991,992 | $691,000 | -$611,000 | $0.19 | 20 |
| 2021 Q4 | 536,516 | $1,229,000 | -$76,912 | $0.76 | 6 |
| 2021 Q3 | 1,294,495 | $1,257,000 | +$15,935 | $0.72 | 16 |
| 2021 Q2 | 1,230,904 | $1,281,000 | +$205,837 | $1.04 | 16 |
| 2021 Q1 | 891,476 | $1,115,000 | +$649,000 | $1.25 | 10 |
| 2020 Q4 | 299,998 | $601,000 | +$601,000 | $3.98 | 3 |
| 2020 Q3 | 0 | $0 | -$13,000 | 0 | |
| 2020 Q1 | 10,000 | $13,000 | $1.30 | 1 |